Generation of iPSC from peripheral blood mononuclear cells obtained from a patient with TSC2-PKD1 contiguous gene deletion syndrome

Stem Cell Res. 2021 Mar:51:102181. doi: 10.1016/j.scr.2021.102181. Epub 2021 Jan 18.

Abstract

TSC2-PKD1 contiguous gene deletion syndrome is characterized by tuberous sclerosis complex and polycystic kidney disease. We obtained peripheral blood mononuclear cells from a patient with TSC2-PKD1 contiguous gene deletion syndrome. We performed reprogramming using non-integrative episomal vectors to obtain human induced pluripotent stem cells (iPSCs). The obtained iPSCs had a normal karyotype and expressed human ES cell-specific cell surface markers and genes; in teratomas, iPSCs differentiated into derivatives of all three germ layers. The iPSCs can be used to study pathogenesis of TSC2-PKD1 contiguous gene deletion syndrome and serve as a potential therapeutic target.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gene Deletion
  • Humans
  • Induced Pluripotent Stem Cells*
  • Leukocytes, Mononuclear
  • TRPP Cation Channels* / genetics
  • Tuberous Sclerosis Complex 2 Protein / genetics
  • Tumor Suppressor Proteins / genetics

Substances

  • TRPP Cation Channels
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Proteins